This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: National Institute of Health and Medical Research, Aventis Pharma S.a., Rhone-Poulenc Rorer S.a.. Active years: 2000-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Illkirsch, FR (2000)
- Illkirch, FR (2009)
Company Filing History:
2 out of 1,853 
1 out of 377 
1 out of 247 Years Active: 2000-2009
Title: Bohdan Wasylyk: Innovator in Transgenic Research
Introduction
Bohdan Wasylyk is a prominent inventor based in Illkirch, France. He has made significant contributions to the field of molecular biology, particularly in the area of transgenic research. With a total of 2 patents, his work focuses on the regulation of gene expression and the development of animal models for human diseases.
Latest Patents
Wasylyk's latest patents include groundbreaking inventions that have the potential to impact therapeutic approaches. One of his patents is titled "Net, a transcription factor of the TCF family, as regulator of angiogenic factor expression." This invention relates to the regulation of the NET protein's activity and includes methods for screening compounds that can modify this activity. It also discusses the use of transgenic animals with mutations in the NET gene to further explore angiogenic factors.
Another significant patent is "Transgenic animals overexpressing MDM2." This invention involves non-human animals that overexpress the MDM2 gene, which is associated with human tumors. These animals exhibit a severe skin disorder known as ichthyosis and are valuable for identifying compounds that may treat diseases affecting the skin and respiratory tract.
Career Highlights
Throughout his career, Wasylyk has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and Rhône-Poulenc Rorer S.A. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Wasylyk has collaborated with notable colleagues, including Bruno Tocque and Moussa Alkhalaf. These partnerships have enriched his research endeavors and fostered innovation in his field.
Conclusion
Bohdan Wasylyk's contributions to transgenic research and gene regulation are noteworthy. His patents reflect a commitment to advancing medical science and improving therapeutic strategies. His work continues to inspire future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile